Haplotypes of the beta-2 adrenergic receptor associate with high diastolic blood pressure in the Caerphilly prospective study

Objectives Current evidence demonstrates that both genetic and environmental factors influence blood pressure. The sympathetic nervous system is a key player in blood pressure control and functional genetic variants of the beta-2 adrenergic receptor (B2AR) have been identified and implicated in the pathogenesis of hypertension. The present study aimed to determine the effects of common haplotypes of the B2AR gene upon blood pressure in the Caerphilly Prospective Study. Design Two thousand five hundred and twelve men (aged 45–59 years) participated in the study. We selected individuals in the upper (n = 347) and lower (n = 279) quintiles of the diastolic blood pressure distribution fixed at two time points [phase 2 (1984–88) or phase 3 (1989–93)] as cases and controls. Methods We analysed two functional polymorphisms (Arg16Gly and Gln27Glu) of B2AR and their haplotypes. Results We found a higher risk of hypertension in individuals homozygous for the Gln27 compared to those individuals homozygous for Glu27 [odds ratio (OR) = 1.94; 95% confidence interval (CI) = 1.34–2.81; P = 0.001]. Three haplotypes (Gly16Gln27, Gly16Glu27 and Arg16Gln27) were present in both quintile groups. Logistic regression analysis showed that haplotypes with a Gln27 allele (Gly16Gln27 and Arg16Gln27) conferred a significantly higher risk for hypertension than the Gly16Glu27 haplotype (OR = 1.55; 95% CI = 1.11–2.17, OR = 1.37; 95% CI = 1.04–1.81; P = 0.009 and P = 0.027, respectively). However, there was no evidence to support a statistically significant difference in odds ratios for the Gly16Gln27 and Arg16Gln27 haplotypes (P = 0.477), suggesting that it is the Gln27 allele alone, rather than any haplotype, which best explains the association. Conclusions In a prospectively studied Caucasian male cohort, high diastolic blood pressure was associated with B2AR haplotypes containing the pro-downregulatory Gln27 variant.

[1]  K. Leineweber,et al.  Beta2-adrenoceptor gene polymorphisms. , 2005, Pharmacogenetics and genomics.

[2]  D. Ge,et al.  β2‐Adrenergic Receptor Gene Variations Associated with Stage‐2 Hypertension in Northern Han Chinese , 2005, Annals of human genetics.

[3]  A. Siani,et al.  Lack of association between polymorphism in the beta2-adrenergic receptor gene, hypertension, and obesity in the Olivetti heart study. , 2004, American journal of hypertension.

[4]  K. Leineweber,et al.  Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes. , 2004, Life sciences.

[5]  P. Insel,et al.  Autonomic Nervous System Pharmacogenomics: A Progress Report , 2004, Pharmacological Reviews.

[6]  H. Bruck,et al.  β-Adrenoceptor polymorphisms , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[7]  H. Bruck,et al.  Beta-adrenoceptor polymorphisms. , 2004, Naunyn-Schmiedeberg's archives of pharmacology.

[8]  Juliet M Chapman,et al.  Detecting Disease Associations due to Linkage Disequilibrium Using Haplotype Tags: A Class of Tests and the Determinants of Statistical Power , 2003, Human Heredity.

[9]  P. Visscher,et al.  Power of Linkage Disequilibrium Mapping to Detect a Quantitative Trait Locus (QTL) in Selected Samples of Unrelated Individuals , 2003, Annals of human genetics.

[10]  Ihab Hajjar,et al.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. , 2003, JAMA.

[11]  D. Rizzoni,et al.  &bgr;2-Adrenergic Receptor Gene Polymorphism, Age, and Cardiovascular Phenotypes , 2003, Hypertension.

[12]  Lon R. Cardon,et al.  Efficient selective screening of haplotype tag SNPs , 2003, Bioinform..

[13]  T. Wadden,et al.  AGA technical review on obesity. , 2002, Gastroenterology.

[14]  A. Dominiczak,et al.  Essential Hypertension and &bgr;2-Adrenergic Receptor Gene: Linkage and Association Analysis , 2002, Hypertension.

[15]  A. Evans,et al.  Polymorphisms of the β2-adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies , 2002, Journal of hypertension.

[16]  Robert J. Lefkowitz,et al.  Seven-transmembrane-spanning receptors and heart function , 2002, Nature.

[17]  K. O’Shaughnessy.  The genetics of essential hypertension. , 2008, British journal of clinical pharmacology.

[18]  R. Kim,et al.  The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. , 2001, The New England journal of medicine.

[19]  Y. Yazaki,et al.  Association Analysis of &bgr;2-Adrenergic Receptor Polymorphisms With Hypertension in Japanese , 2001, Hypertension.

[20]  N. Schork,et al.  Linkage disequilibrium analysis of biallelic DNA markers, human quantitative trait loci, and threshold-defined case and control subjects. , 2000, American journal of human genetics.

[21]  R S Judson,et al.  Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. O'Connor,et al.  β2-Adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans. , 2000 .

[23]  E. Boerwinkle,et al.  Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. , 2000, Circulation.

[24]  J. Haines,et al.  Human β2‐adrenergic receptor polymorphisms: No association with essential hypertension in black or white Americans , 2000, Clinical pharmacology and therapeutics.

[25]  S. Liggett,et al.  beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. , 2000, American heart journal.

[26]  Jeanine J. Houwing-Duistermaat,et al.  Power of Selective Genotyping in Genetic Association Analyses of Quantitative Traits , 2000, Behavior genetics.

[27]  N. Samani,et al.  Association analysis of β2 adrenoceptor polymorphisms with hypertension in a Black African population , 2000, Journal of hypertension.

[28]  D. O'Connor,et al.  Beta2-adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans. , 2000, American journal of hypertension.

[29]  F Skrabal,et al.  beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. , 1999, Hypertension.

[30]  Magnus Jobs,et al.  Dynamic allele-specific hybridization , 1999, Nature Biotechnology.

[31]  A. Brookes,et al.  Dynamic allele-specific hybridization. A new method for scoring single nucleotide polymorphisms. , 1999, Nature biotechnology.

[32]  T. Wienker,et al.  Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. , 1998, Kidney international.

[33]  M. Caulfield,et al.  Essential hypertension in African Caribbeans associates with a variant of the beta2-adrenoceptor. , 1997, Hypertension.

[34]  P. Sham.  Statistics in human genetics , 1997 .

[35]  M. Caulfield,et al.  A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. , 1995, Circulation.

[36]  S. Green,et al.  Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. , 1994, Biochemistry.

[37]  P. Elwood,et al.  DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[38]  M. O'Rourke,et al.  Wave reflection in the systemic circulation and its implications in ventricular function. , 1993, Journal of hypertension.

[39]  D. W. Gray,et al.  Novel signal transduction pathway mediating endothelium‐dependent β‐adrenoceptor vasorelaxation in rat thoracic aorta , 1992, British journal of pharmacology.

[40]  W. Nichols,et al.  Determinants of isolated systolic hypertension in the elderly , 1992, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[41]  J. Weller,et al.  On the use of the moments method of estimation to obtain approximate maximum likelihood estimates of linkage between a genetic marker and a quantitative locus , 1992, Heredity.

[42]  G. Carey,et al.  Linkage analysis of quantitative traits: increased power by using selected samples. , 1991, American journal of human genetics.

[43]  Wolfgang Babisch,et al.  Traffic noise, work noise and cardiovascular risk factors : the Caerphilly and Speedwell collaborative heart disease studies , 1990 .

[44]  E. Lander,et al.  Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. , 1989, Genetics.

[45]  A. Fehily,et al.  Caerphilly and Speedwell collaborative heart disease studies. The Caerphilly and Speedwell Collaborative Group. , 1984, Journal of epidemiology and community health.